First human test of new Heart-Kidney drug completed
NCT ID NCT06675175
Summary
This early-stage study tested the safety of an experimental oral drug called AZD4144 in people with both heart and kidney disease. Twenty-nine participants took either the drug or a placebo pill daily for 28 days. The main goal was to see if the drug was safe and to measure its effects on inflammation in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91203, United States
-
Research Site
Daytona Beach, Florida, 32117, United States
-
Research Site
Jacksonville, Florida, 32216, United States
-
Research Site
Miami, Florida, 33125, United States
-
Research Site
Port Orange, Florida, 32127, United States
-
Research Site
Tampa, Florida, 33603, United States
-
Research Site
Farmington Hills, Michigan, 48334, United States
-
Research Site
The Bronx, New York, 10455, United States
-
Research Site
Sherman, Texas, 75092, United States
-
Research Site
Pleven, 5800, Bulgaria
-
Research Site
Sofia, 1527, Bulgaria
-
Research Site
Gyöngyös, 3200, Hungary
-
Research Site
Kistarcsa, 2143, Hungary
-
Research Site
Bucharest, 11658, Romania
-
Research Site
Cluj-Napoca, 400006, Romania
Conditions
Explore the condition pages connected to this study.